Clinical trial
Understanding Imaging Biomarkers That Predict the Progression of Age-Related Macular Degeneration on Multi-modal Novel Retinal Technologies
NCT04537143 is registered in ClinicalTrials.gov with Doheny Image Reading Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding Imaging Biomarkers That Predict the Progression of Age-Related Macular Degeneration on Multi-modal Novel Retinal Technologies
- Lead sponsor
- Doheny Image Reading Center
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- January 31, 2021
- Completion date
- January 31, 2023
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
amd